10x Genomics (TXG) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Genomics (TXG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Business Wire20h
Parse Biosciences Invalidates All 10x Genomics’ Patent Claims Asserted Against Its Products
Parse Biosciences, a leader in accessible and scalable single cell sequencing solutions, today ...
Hosted on MSN21h
Cathie Wood’s ARK Investment buys 120K shares of 10x Genomics today
EST Cathie Wood’s ARK Investment buys 120K shares of 10x Genomics (TXG) today Published first on TheFly – the ultimate source for real-time, ...
Cathie Wood's ARK buys Illumina stock, trims Palantir
Cathie Wood's ARK ETFs have once again made notable adjustments to their portfolios, as revealed in their daily trade report for Tuesday, February 4th, 2025. The most significant move was the sale of ...